Franklin Resources Inc Alkermes Plc. Transaction History

Franklin Resources Inc

$313 Billion
Q2 2024

A detailed history of Franklin Resources Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Franklin Resources Inc holds 117,103 shares of ALKS stock, worth $3.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

117,103

Previous 226,592 48.32%

Holding current value

$3.26 Million

Previous $6.13 Million 53.99%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$23.21 - $27.24 $2.54 Million - $2.98 Million	-109,489 Reduced 48.32%	117,103 $2.82 Million
Q1 2024 May 13, 2024	BUY	$26.4 - $32.56 $2.16 Million - $2.67 Million	81,852 Added 56.55%	226,592 $6.13 Million
Q4 2023 Feb 09, 2024	SELL	$23.37 - $28.68 $316,196 - $388,040	-13,530 Reduced 8.55%	144,740 $4.02 Million
Q3 2023 Nov 13, 2023	SELL	$27.17 - $31.97 $277,106 - $326,062	-10,199 Reduced 6.05%	158,270 $4.43 Million
Q2 2023 Aug 11, 2023	BUY	$28.34 - $33.63 $2.31 Million - $2.74 Million	81,391 Added 93.47%	168,469 $5.27 Million
Q1 2023 May 12, 2023	BUY	$25.31 - $29.02 $3,315 - $3,801	131 Added 0.15%	87,078 $2.45 Million
Q4 2022 Feb 10, 2023	BUY	$21.94 - $26.24 $11,935 - $14,274	544 Added 0.63%	86,947 $2.27 Million
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $1.14 Million - $1.65 Million	51,758 Added 149.4%	86,403 $1.93 Million
Q2 2022 Aug 11, 2022	SELL	$26.4 - $30.54 $204,362 - $236,410	-7,741 Reduced 18.26%	34,645 $1.03 Million
Q1 2022 May 13, 2022	BUY	$23.07 - $27.99 $160,359 - $194,558	6,951 Added 19.62%	42,386 $1.12 Million
Q4 2021 Feb 11, 2022	BUY	$21.47 - $32.08 $112,030 - $167,393	5,218 Added 17.27%	35,435 $824,000
Q3 2021 Nov 12, 2021	BUY	$23.37 - $32.13 $706,171 - $970,872	30,217 New	30,217 $932,000
Q3 2019 Nov 14, 2019	SELL	$19.51 - $24.28 $50.8 Million - $63.3 Million	-2,605,710 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$21.47 - $37.33 $44.8 Million - $77.9 Million	-2,087,278 Reduced 44.48%	2,605,710 $58.7 Million
Q1 2019 May 14, 2019	BUY	$28.4 - $36.49 $8.72 Million - $11.2 Million	306,988 Added 7.0%	4,692,988 $171 Million
Q4 2018 Feb 12, 2019	BUY	$27.94 - $44.61 $3.36 Million - $5.36 Million	120,200 Added 2.82%	4,386,000 $129 Million
Q3 2018 Nov 13, 2018	BUY	$38.6 - $46.12 $7.96 Million - $9.51 Million	206,300 Added 5.08%	4,265,800 $181 Million
Q2 2018 Aug 14, 2018	BUY	$40.56 - $51.36 $42.6 Million - $53.9 Million	1,050,170 Added 34.9%	4,059,500 $167 Million
Q1 2018 May 10, 2018	SELL	$53.61 - $67.26 $7.47 Million - $9.37 Million	-139,270 Reduced 4.42%	3,009,330 $174 Million
Q4 2017 Feb 14, 2018	SELL	$47.69 - $55.39 $1.59 Million - $1.84 Million	-33,300 Reduced 1.05%	3,148,600 $172 Million
Q3 2017 Nov 13, 2017	BUY	$49.16 - $54.45 $156 Million - $173 Million	3,181,900	3,181,900 $162 Million

Others Institutions Holding ALKS

# of Institutions

346

Shares Held

183M

Call Options Held

209K

Put Options Held

89.4K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.57B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Alkermes Plc. Transaction History